Blackstone, Carlyle and KKR Offer $11.1B For Life Tech.

Apr 12 2013 | 10:13am ET

Three private equity firms have bid $11.1 billion for genetic testing equipment maker Life Technologies, expected to be among the biggest buyouts of the year.

The Blackstone Group, the Carlyle Group and Kohlberg Kravis Roberts, along with Singapore state investment company Temasek Holdings, offered $65 per share for the company. But that opening bid is thought to fall short of the between $65 and $75 per share offered by Thermo Fisher Scientific.

Life Technologies is reviewing the bids and is expected to open negotiations with both bidding groups. A deal could be completed within a few days, The Wall Street Journal reports.


In Depth

Q&A: Rotation Capital's Rothfleisch On SPAC 2.0

Aug 11 2017 | 7:43pm ET

Corporate actions have long been a staple of event-driven investors, but activity...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Star Mountain: Private Lending in the Lower Middle-Market

Aug 14 2017 | 4:45pm ET

Private credit has become one of the most popular alternative asset classes in recent...

 

From the current issue of